Health authorities were refusing to fund alpha interferon due to its cost and belief it was of limited clinical effectiveness. Linked evidence EXPG0000001 - Expert Report to the Infected Blood Inquiry Hepatitis - 01 Jan 2020 Chronology Information Date: 13 November 1997 Chapter/issue Access to Treatment